A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio® ) in cardiac surgery: the REVAKI-1 study.
about
A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio® ) in cardiac surgery: the REVAKI-1 study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A Phase I study to determine t ...... c surgery: the REVAKI-1 study.
@en
A Phase I study to determine t ...... c surgery: the REVAKI-1 study.
@nl
type
label
A Phase I study to determine t ...... c surgery: the REVAKI-1 study.
@en
A Phase I study to determine t ...... c surgery: the REVAKI-1 study.
@nl
prefLabel
A Phase I study to determine t ...... c surgery: the REVAKI-1 study.
@en
A Phase I study to determine t ...... c surgery: the REVAKI-1 study.
@nl
P2093
P2860
P50
P356
P1476
A Phase I study to determine t ...... c surgery: the REVAKI-1 study.
@en
P2093
Gavin J Murphy
Nigel Brunskill
Rakesh Vaja
Tom Morris
Tracy Kumar
Veerle Verheyden
William Dott
P2860
P304
P356
10.1111/BCP.13162
P407
P577
2016-12-01T00:00:00Z